[ Price : $8.95]
A physician survey conducted by UCSF researchers finds many doctors dont understand how FDA approves new drugs and medical devices...[ Price : $8.95]
Hemogenyx Pharmaceuticals files its complete response to an FDA HEMO-CAR-T clinical hold in hopes of starting Phase 1 trials.[ Price : $8.95]
FDA publishes the summary of an October 2023 public meeting on continuing the Covid-19 lessons learned for modernization and innov...[ Price : $8.95]
A month after gaining FDA approval for treating sickle cell disease with the gene therapy Casgevy, Vertex secures its second appro...[ Price : $8.95]
Federal Register notice: FDA announces the approval of a product that redeemed a material threat medical countermeasure priority r...[ Price : $8.95]
FDA alerts patients and healthcare providers about Exactechs Equinoxe Shoulder System joint replacement devices and possible healt...[ Price : $8.95]
ROi CPS recalls its Regard Operative Lap P&S Surgical Kit due to sterility concerns.[ Price : $8.95]
FDA grants Hyloris Pharmaceuticals an orphan drug designation for PTX-252 for treating acute myeloid leukemia.